← Back to Search

Device

Spinal Cord Stimulation for Peripheral Neuropathy

N/A
Waitlist Available
Led By Matthew Chung, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥18 years
Diagnosis history of CIPN of lower extremities
Must not have
Patients with active infection, being treated with antibiotics
Patients with brain metastases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to see how closed loop spinal cord stimulation can help patients with painful nerve damage caused by chemotherapy. They will measure changes in pain levels, quality of life, use of pain medications, sensory

Who is the study for?
This trial is for individuals suffering from painful peripheral neuropathy caused by chemotherapy. Participants should have a history of cancer treatment-related nerve pain in their limbs and be seeking relief.
What is being tested?
The study tests the effectiveness of a spinal cord stimulator implant to alleviate pain, improve life quality, reduce pain medication use, enhance sensory function, and better gait in patients with chemotherapy-induced nerve damage.
What are the potential side effects?
Potential side effects may include discomfort at the implant site, infection risk, possible changes in sensation or unexpected stimulation effects due to the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have nerve damage in my legs due to chemotherapy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently being treated with antibiotics for an active infection.
Select...
I have cancer that has spread to my brain.
Select...
I am currently receiving chemotherapy or immunotherapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Numerical Rating Scale (NRS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: SCS ImplantationExperimental Treatment1 Intervention
Participants will be screened on a weekly basis in the Pain Management Clinic

Find a Location

Who is running the clinical trial?

Saluda Medical Pty LtdIndustry Sponsor
8 Previous Clinical Trials
663 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
3,070 Previous Clinical Trials
1,802,798 Total Patients Enrolled
Matthew Chung, MDPrincipal InvestigatorThe University of Texas MD Anderson Cancer Center
~7 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top